ATTERX BIOTHERAPEUTICS
Lobbying client. Federal LDA filings.
- Source id
56321- General description
- Biotherapeutical development
- State
- WI
- Country
- US
- Principal place of business
- US
- Effective date
- 2023-04-03
- Total spend (across 1 ingested filings)
- $15,000
Filings (1) — $15,000
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-05-18 | Q1 | 2026 | CAPSTONE NATIONAL PARTNERS | $15,000 |
Connected on the graph
2 typed relationships in the influence graph — 2 inbound, 0 outbound, grouped by type.
lobbied for (2)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| — | ← | Christopher Paul Czarnecki | — | lda_lobbyist_client | |
| — | ← | William Stone | — | lda_lobbyist_client |